Mechanical Ventilation after Marrow Transplantation: Risk Factors and Clinical Outcome
- 29 February 1988
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 137 (3), 682-687
- https://doi.org/10.1164/ajrccm/137.3.682
Abstract
The risk factors for and the outcome of mechanical ventilatory support after marrow transplantation were analyzed in 1,089 consecutive marrow recipients. Of 232 patients receiving ventilatory support at this center, 63 (27%) survived an initial episode of ventilatory support. In contrast, 74% of nonventilated patients survived at least 6 months after transplantation. Among patients with malignant disease (n = 992), a multivariate regression model revealed 3 pretransplant factors that were associated with ventilatory support: age ⩾ 21 yr (RR = 1.6,95% confidence intervals [CI] = 1.3, 2.0), hematologic malignancy in relapse (RR = 2.1, 95% CI = 1.7, 2.4), and HLA nonidentical donor-recipient pair (nonidentical graft) (RR = 1.7, 95% CI = 1.4, 2.1). Survival after ventilatory support was not found to be associated with any pretransplant or post-transplant factors examined. We conclude that although the risk factors for mechanical ventilatory support after marrow transplantation can be defined, we are unable to identify characteristics predictive of survival after such support. The implications of these findings in relation to patient selection and future research activities are discussed.This publication has 17 references indexed in Scilit:
- Successful Intermittent Chemoprophylaxis forPneumocystis cariniiPneumonitisNew England Journal of Medicine, 1987
- Clinical Outcome of Respiratory Failure in Patients Requiring Prolonged (>24 Hours) Mechanical VentilationChest, 1986
- Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft- versus-host diseaseBlood, 1985
- Precedents for meaningful recovery during treatment in a medical intensive care unitAmerican Journal Of Medicine, 1983
- Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' ExperienceClinical Infectious Diseases, 1982
- Toxicity and Efficacy of Human Leukocyte Interferon for Treatment of Cytomegalovirus Pneumonia after Marrow TransplantationThe Journal of Infectious Diseases, 1980
- Successful Chemoprophylaxis forPneumocystis cariniiPneumonitisNew England Journal of Medicine, 1977